Skip to content

A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease

A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease - The efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of Parkinson's disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001576
Enrollment
150
Registered
2008-12-17
Start date
2008-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Repetitive transcranial magnetic stimulation over the supplementary motor area, high-frequency stimulation Repetitive transcranial magnetic stimulation over the supplementary motor area, low-frequency

Sponsors

Department of neurology, Fukushima medical university
Lead Sponsor
Univ: Occupational Environ Health,Tokushima,Kyusyu,Tottori,Tokyo,Hokkaido,Saitama Med,Osaka, Hamamatsu Med,Kinki) Tokyo neurological hos,Kumamoto Kinoh hos, Nagasaki Med center of Neurol
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Diagnosed as Parkinson's disease (PD) according to the UK Parkinson's disease Society brain bank 2) Patients who are capable of ambulatory hospital visits 3)Patients who consented to keep drug and living conditions during the study. 4)Patients who were rated as Hoehn-Yahr grade 2 or 3 or 4. 5) Those who give us informed consent to participate in the present study after detailed explanation of the study

Exclusion criteria

Exclusion criteria: 1)The patients who underwent the TMS treatment before 2)No implantation of metal in head, except in the mouth 3) Those having heart pacemaker or drug infusion pomp 4) Serious heart disease 5)History of massive cerebral infarction, head injury, brain tumor, or epilepsy 6)Pregnant or intend to be pregnant

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale(UPDRS) part 3

Secondary

MeasureTime frame
UPDRS part 1,2,4, 5-point scale for daily life and tremor, Apathy scale, 17 item of Hamilton depression scale, Non-Motor Symptoms Questionnaire

Countries

Japan

Contacts

Public ContactHiroyuki Enomoto

Fukushima medical university Department of neurology

024-547-1248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026